Catalyst Wire Dossier Catalyst Wire Dossier

BI 1026706

BI 1026706 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for BI 1026706, covering 2019-03-20 to 2019-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD [Phase 1]

See pricing